Belgium's IntelliProve has raised €1 million of seed funds from investors including imec.istart Fund, the venture fund aligned to research institute Imec's istart accelerator.
IntelliProve's platform enables doctors and mental health practitioners to enrich patient consultations by using a conventional smart phone camera to determine their condition.
Not only that, it has embedded biomarkers for mental state, blood oxygen, respiratory rate and blood pressure, using just a recording of the patient's facial expression, body language and a standard finger pulse oximeter, often found in doctor's surgeries.
Ghent-based IntelliProve says its tech is an initial step toward "digital biopsies" that greatly enhance preventative healthcare — empowering doctors to encourage good lifestyle choices before critical health issues arise.
Through its smartphone app and API, the startup is using novel signal processing and computer vision-driven artificial intelligence at the heart of its software, allowing readings to be taken without use of wearable connected devices.
IntelliProve's €1 million seed raise was also backed by Flanders home nursing nonprofit The White and Yellow Cross, state innovation agency VLAiO (which also awarded money from state grants) and other private investors.
The software is still to launch, and right now IntelliProve is looking to finish product testing.
Co-founder and CEO, Joeri Tulkens, said: "This capital injection and trust from our investors shows the importance of our health monitoring solution, which increases the quality and engagement of patient-centreed digital healthcare solutions.
"We’re grateful and humbled to be playing a role in today’s healthcare landscape.”